ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Adiso Therapeutics Limited

Adiso Therapeutics Limited is an active company incorporated on 24 November 2021 with the registered office located in Altrincham, Greater Manchester. Adiso Therapeutics Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13763654
Private limited company
Age
4 years
Incorporated 24 November 2021
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 23 November 2025 (1 month ago)
Next confirmation dated 23 November 2026
Due by 7 December 2026 (11 months remaining)
Last change occurred 1 year 1 month ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Audited Abridged
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
3rd Floor 1 Ashley Road
Altrincham
Cheshire
WA14 2DT
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
3
Shareholders
11
Controllers (PSC)
2
Director • American • Lives in United States • Born in Apr 1975
Director • American • Lives in United States • Born in Sep 1962
Director • American • Lives in United States • Born in Feb 1976
Adriel Wenbwo Chan
PSC • Hong Konger • Lives in Hong Kong • Born in Jul 1982
Yuk Lan Wong
PSC • Hong Konger • Lives in Hong Kong • Born in Mar 1967
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Revolo Biotherapeutics Limited
Isaac S. Cheng is a mutual person.
Active
Thirty Holdings Limited
Isaac S. Cheng is a mutual person.
Active
30 Technology Limited
Isaac S. Cheng is a mutual person.
Active
Medannex Limited
Isaac S. Cheng is a mutual person.
Active
Vaxequity Ltd
Dr Jason Robert Dinges is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£305K
Increased by £146K (+92%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£36.03M
Increased by £729K (+2%)
Total Liabilities
-£32.45M
Increased by £7.23M (+29%)
Net Assets
£3.58M
Decreased by £6.5M (-64%)
Debt Ratio (%)
90%
Increased by 18.62% (+26%)
Latest Activity
Confirmation Submitted
1 Month Ago on 5 Dec 2025
Abridged Accounts Submitted
3 Months Ago on 2 Oct 2025
Abridged Accounts Submitted
1 Year Ago on 19 Dec 2024
Confirmation Submitted
1 Year 1 Month Ago on 26 Nov 2024
Robert Lisicki Resigned
1 Year 6 Months Ago on 1 Jul 2024
Small Accounts Submitted
1 Year 11 Months Ago on 19 Jan 2024
Robert Lisicki Appointed
2 Years Ago on 22 Dec 2023
Confirmation Submitted
2 Years 1 Month Ago on 1 Dec 2023
Compulsory Strike-Off Discontinued
2 Years 2 Months Ago on 25 Oct 2023
Dr Jason Robert Dinges Details Changed
3 Years Ago on 31 Aug 2022
Get Credit Report
Discover Adiso Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 23 November 2025 with no updates
Submitted on 5 Dec 2025
Audited abridged accounts made up to 31 December 2024
Submitted on 2 Oct 2025
Audited abridged accounts made up to 31 December 2023
Submitted on 19 Dec 2024
Confirmation statement made on 23 November 2024 with updates
Submitted on 26 Nov 2024
Termination of appointment of Robert Lisicki as a director on 1 July 2024
Submitted on 7 Oct 2024
Statement of capital following an allotment of shares on 18 May 2024
Submitted on 7 Jun 2024
Appointment of Robert Lisicki as a director on 22 December 2023
Submitted on 26 Feb 2024
Accounts for a small company made up to 31 December 2022
Submitted on 19 Jan 2024
Director's details changed for Dr Jason Robert Dinges on 31 August 2022
Submitted on 1 Dec 2023
Confirmation statement made on 23 November 2023 with no updates
Submitted on 1 Dec 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year